People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Liquid BioScience, Inc. | — | Biotechnology | Series B | $40.0M | $1.6B | 2017 |
| Emerald Logic, Inc. | — | Other Technology | Series A | $7.9M | $26.4M | 2011 |
| BluePrint Bio, Inc. | — | Biotechnology | Pre-Seed | $1.3M | $43.6M | 2015 |
Patrick Lilley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Lilley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Nunez | 2 | 4 |
| Dennis Kogod | 2 | 2 |
| Patrick O'Neill | 1 | 14 |
| John Harbison | 1 | 6 |
| Michael O'Neill | 1 | 4 |
| Franklyn Prendergast | 1 | 2 |
| Barry Straube | 1 | 1 |
| Harbison John | 1 | 1 |
| Matt Nunez | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.